Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$194.44 - $217.61 $73,498 - $82,256
-378 Reduced 10.74%
3,140 $615,000
Q2 2023

Aug 14, 2023

BUY
$183.71 - $210.25 $56,582 - $64,757
308 Added 9.6%
3,518 $739,000
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $243,124 - $329,318
1,267 Added 65.21%
3,210 $647,000
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $87,713 - $111,281
445 Added 29.71%
1,943 $423,000
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $273,295 - $375,308
1,498 New
1,498 $295,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.33B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Mid West One Financial Group, Inc. Portfolio

Follow Mid West One Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mid West One Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mid West One Financial Group, Inc. with notifications on news.